TSL Express Daily News

The Secured Lender

TSL-NOV24-COVR 

SFNet's 80th Annual Convention Issue
 

Intro content. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Curabitur iaculis sapien sagittis, accumsan magna ut, blandit massa. Quisque vehicula leo lorem, a tincidunt eros tempor nec. In quis lacus vitae risus egestas tincidunt. Phasellus nulla risus, sodales in purus non, euismod ultricies elit. Vestibulum mattis dolor non sem euismod interdum.

November 4, 2024

Source: Businesswire

NEW YORK--(BUSINESS WIRE)--Marathon Asset Management (“Marathon”), a leading global credit manager with more than $23 billion of assets under management, is pleased to announce the closing of a senior-secured credit facility to finance H.I.G. Capital’s (“H.I.G.”) acquisition of SkinCure Oncology Intermediate LLC (“SkinCure Oncology”). SkinCure Oncology’s executive team, led by CEO Kerwin Brandt, will continue to lead the company and remain significant shareholders.

SkinCure Oncology is a leading provider of image-guided superficial radiation therapy (IG-SRT), a non-invasive treatment primarily for nonmelanoma skin cancer (NMSC). Unlike conventional surgical approaches, IG-SRT requires no incisions or reconstructive surgery, allowing patients to carry on with normal activities, while also offering cosmetic benefits for patients worried about scarring. SkinCure Oncology’s GentleCure™ Experience, IG-SRT is accessible through more than 500 physicians nationwide, with over 100,000 patients treated using this technology.

“SkinCure Oncology has a tremendous track record for delivering outcomes for both its physician partners and patients,” said Curtis Lueker, Marathon’s Head of Direct Lending. “The company is an established leader in the industry, and we are excited to partner with H.I.G. and their strong management team to execute on their strategic vision and expansion to provide increased options and access to care for patients with NMSC.”

“The power of Marathon's integrated investment platform, utilizing the expertise and combined capabilities of our dedicated Healthcare Finance and Direct Lending teams, enabled us to provide a reliable, thoughtful, and efficient financing solution for a best-in-class sponsor in H.I.G.,” said Bruce Richards, Marathon’s Chairman and CEO. “Marathon’s Private Credit platform is designed as a one-stop shop, offering corporate, asset-based, and capital solutions, including senior and junior financings ranging from $50 million to $250 million.”

About Marathon Asset Management:

Marathon Asset Management, L.P. is a leading global asset manager specializing in the Public and Private Credit markets with $23 billion of assets under management. Marathon has dedicated investment programs spanning the spectrum of Private Credit: Direct Lending, Asset-Based Lending and Opportunistic as well as the spectrum of Public Credit. Marathon was founded in 1998 and is managed by Bruce Richards (Co-Founder & CEO) and Louis Hanover (Co-Founder & CIO) and employs more than 180 professionals, with 8 Partners. Its corporate headquarters are located in New York City, and it has offices in London, Miami, Los Angeles and Luxembourg. Marathon is a Registered Investment Adviser with the Securities Exchange Commission. For more information, please visit the company's website at www.marathonfund.com.

Contacts

Marathon Asset Management Media Inquiries
Prosek Partners
pro-marathon@prosek.com
646-818-9283